What is Exagen Inc.'s fair value adjustment of warrants?

Exagen Inc. (XGN) reported fair value adjustment of warrants of -$882K in Q1 2026.

What does fair value adjustment of warrants mean?

This metric captures the non-cash gain or loss resulting from changes in the fair market value of outstanding warrant liabilities. Because these instruments are often revalued at each reporting period based on stock price volatility and other factors, this adjustment reflects market-driven fluctuations rather than core operational performance. It is essential for isolating the impact of derivative accounting on the company's net income.

Exagen Inc. XGN Fair Value Adjustment Of Warrants

Fair Value Adjustment Of Warrants at other companies

Vor BiopharmaVOR

$188.36M—

Biodesix, Inc.BDSX

$200K—

Segments

By segment

See full

Reportable Segment-$882K—

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s fair value adjustment of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s fair value adjustment of warrants?: Exagen Inc. (XGN) reported fair value adjustment of warrants of -$882K in Q1 2026.
What does fair value adjustment of warrants mean?: This metric captures the non-cash gain or loss resulting from changes in the fair market value of outstanding warrant liabilities. Because these instruments are often revalued at each reporting period based on stock price volatility and other factors, this adjustment reflects market-driven fluctuations rather than core operational performance. It is essential for isolating the impact of derivative accounting on the company's net income.